Stable long‐term cultures of self‐renewing B cells and their applications
Identifieur interne : 000468 ( Main/Exploration ); précédent : 000467; suivant : 000469Stable long‐term cultures of self‐renewing B cells and their applications
Auteurs : Mark J. Kwakkenbos [Pays-Bas] ; Pauline M. Van Helden [Pays-Bas] ; Tim Beaumont [Pays-Bas] ; Hergen Spits [Pays-Bas]Source :
- Immunological Reviews [ 0105-2896 ] ; 2016-03.
Abstract
Monoclonal antibodies are essential therapeutics and diagnostics in a large number of diseases. Moreover, they are essential tools in all sectors of life sciences. Although the great majority of monoclonal antibodies currently in use are of mouse origin, the use of human B cells to generate monoclonal antibodies is increasing as new techniques to tap the human B cell repertoire are rapidly emerging. Cloned lines of immortalized human B cells are ideal sources of monoclonal antibodies. In this review, we summarize our studies to the regulation of the replicative life span, differentiation, and maturation of B cells that led to the development of a platform that uses immortalization of human B cells by in vitro genetic modification for antibody development. We describe a number of human antibodies that were isolated using this platform and the application of the technique in other species. We also discuss the use of immortalized B cells as antigen‐presenting cells for the discovery of tumor neoantigens.
Url:
DOI: 10.1111/imr.12395
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001684
- to stream Istex, to step Curation: 001684
- to stream Istex, to step Checkpoint: 000002
- to stream Main, to step Merge: 000468
- to stream Main, to step Curation: 000468
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Stable long‐term cultures of self‐renewing B cells and their applications</title><author><name sortKey="Kwakkenbos, Mark J" sort="Kwakkenbos, Mark J" uniqKey="Kwakkenbos M" first="Mark J." last="Kwakkenbos">Mark J. Kwakkenbos</name></author><author><name sortKey="Van Helden, Pauline M" sort="Van Helden, Pauline M" uniqKey="Van Helden P" first="Pauline M." last="Van Helden">Pauline M. Van Helden</name></author><author><name sortKey="Beaumont, Tim" sort="Beaumont, Tim" uniqKey="Beaumont T" first="Tim" last="Beaumont">Tim Beaumont</name></author><author><name sortKey="Spits, Hergen" sort="Spits, Hergen" uniqKey="Spits H" first="Hergen" last="Spits">Hergen Spits</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4E1C94B38CDEF71016B7DD930B414A7336830441</idno><date when="2016" year="2016">2016</date><idno type="doi">10.1111/imr.12395</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-79SH464W-C/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001684</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001684</idno><idno type="wicri:Area/Istex/Curation">001684</idno><idno type="wicri:Area/Istex/Checkpoint">000002</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000002</idno><idno type="wicri:doubleKey">0105-2896:2016:Kwakkenbos M:stable:long:term</idno><idno type="wicri:Area/Main/Merge">000468</idno><idno type="wicri:Area/Main/Curation">000468</idno><idno type="wicri:Area/Main/Exploration">000468</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Stable long‐term cultures of self‐renewing B cells and their applications</title><author><name sortKey="Kwakkenbos, Mark J" sort="Kwakkenbos, Mark J" uniqKey="Kwakkenbos M" first="Mark J." last="Kwakkenbos">Mark J. Kwakkenbos</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>AIMM Therapeutics, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Van Helden, Pauline M" sort="Van Helden, Pauline M" uniqKey="Van Helden P" first="Pauline M." last="Van Helden">Pauline M. Van Helden</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>AIMM Therapeutics, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Beaumont, Tim" sort="Beaumont, Tim" uniqKey="Beaumont T" first="Tim" last="Beaumont">Tim Beaumont</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>AIMM Therapeutics, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Spits, Hergen" sort="Spits, Hergen" uniqKey="Spits H" first="Hergen" last="Spits">Hergen Spits</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>AIMM Therapeutics, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation><affiliation wicri:level="4"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName><orgName type="university">Université d'Amsterdam</orgName></affiliation><affiliation></affiliation><affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Immunological Reviews</title><title level="j" type="sub">Immunoglobulins: from genes to therapies</title><title level="j" type="alt">IMMUNOLOGICAL REVIEWS</title><idno type="ISSN">0105-2896</idno><idno type="eISSN">1600-065X</idno><imprint><biblScope unit="vol">270</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="65">65</biblScope><biblScope unit="page" to="77">77</biblScope><biblScope unit="page-count">13</biblScope><date type="published" when="2016-03">2016-03</date></imprint><idno type="ISSN">0105-2896</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0105-2896</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Monoclonal antibodies are essential therapeutics and diagnostics in a large number of diseases. Moreover, they are essential tools in all sectors of life sciences. Although the great majority of monoclonal antibodies currently in use are of mouse origin, the use of human B cells to generate monoclonal antibodies is increasing as new techniques to tap the human B cell repertoire are rapidly emerging. Cloned lines of immortalized human B cells are ideal sources of monoclonal antibodies. In this review, we summarize our studies to the regulation of the replicative life span, differentiation, and maturation of B cells that led to the development of a platform that uses immortalization of human B cells by in vitro genetic modification for antibody development. We describe a number of human antibodies that were isolated using this platform and the application of the technique in other species. We also discuss the use of immortalized B cells as antigen‐presenting cells for the discovery of tumor neoantigens.</div></front></TEI><affiliations><list><country><li>Pays-Bas</li></country><region><li>Hollande-Septentrionale</li></region><settlement><li>Amsterdam</li></settlement><orgName><li>Université d'Amsterdam</li></orgName></list><tree><country name="Pays-Bas"><region name="Hollande-Septentrionale"><name sortKey="Kwakkenbos, Mark J" sort="Kwakkenbos, Mark J" uniqKey="Kwakkenbos M" first="Mark J." last="Kwakkenbos">Mark J. Kwakkenbos</name></region><name sortKey="Beaumont, Tim" sort="Beaumont, Tim" uniqKey="Beaumont T" first="Tim" last="Beaumont">Tim Beaumont</name><name sortKey="Spits, Hergen" sort="Spits, Hergen" uniqKey="Spits H" first="Hergen" last="Spits">Hergen Spits</name><name sortKey="Spits, Hergen" sort="Spits, Hergen" uniqKey="Spits H" first="Hergen" last="Spits">Hergen Spits</name><name sortKey="Van Helden, Pauline M" sort="Van Helden, Pauline M" uniqKey="Van Helden P" first="Pauline M." last="Van Helden">Pauline M. Van Helden</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000468 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000468 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:4E1C94B38CDEF71016B7DD930B414A7336830441
|texte= Stable long‐term cultures of self‐renewing B cells and their applications
}}
| This area was generated with Dilib version V0.6.33. |  |